Back to top

Tale of the Tape

Zacks Equity Research

Earnings Estimates Moving Higher for Cogentix Medical (CGNT): Time to Buy?
November 29, 2016

CGNT

Trades from $3

Cogentix Medical, Inc. (CGNT - Free Report) is a medical device manufacturer that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on CGNT’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Cogentix Medical could be a solid choice for investors.  

Current Quarter Estimates for CGNT

In the past 30 days, 1 estimate has gone higher for Cogentix Medical while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from a loss of 3 cents a share 30 days ago, to breakeven level today, a significant move.

Current Year Estimates for CGNT

Meanwhile, Cogentix Medical’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, while none have gone lower in the same time period. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of 21 cents per share 30 days ago to a loss of 14 cents per share today, an increase of 33.3%.

COGENTIX MEDICL Price and Consensus

COGENTIX MEDICL Price and Consensus | COGENTIX MEDICL Quote

Bottom Line

The stock has also started to move higher lately, adding 26.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

COGENTIX MEDICL (CGNT) - free report >>